Company Monitoring Page for Novo-Nordisk

latest headlines for company on cafepharma

Novo Nordisk And A Questionable Form Of Victoza Promotion?
Pharmalot
Wed, 09/25/13 - 10:35 am
Tags:
Novo Nordisk, Victoza, diabetes
Lilly Bets Quality Will Pay Off in U.S. Diabetes Battle
Bloomberg
Wed, 09/25/13 - 08:41 am
Tags:
Eli Lilly, diabetes, Novo Nordisk, Bristol-Myers Squibb, Merck
CHMP thumbs up for 11 new drugs
Pharma Times, UK
Mon, 09/23/13 - 09:33 am
Tags:
Europe, drug approvals, Kadcyla, Roche, Bayer, Xofigo, Abilify Maintena, Otsuka, Lundbeck, Memantine Accord, Accord Healthcare, Levodopa Carbidopa Entacapone Sandoz, Orion, Vitekta, Gilead, Janssen-Cilag, Invokana, Novo Nordisk, NovoEight, AstraZeneca, Fluenz Tetra, GSK, Relvar Ellipta, Lidocaine/Prilocaine Plethora, Plethora Solutions
Novo Nordisk Hemophilia-A Treatment Wins EU Panel Backing
Bloomberg
Fri, 09/20/13 - 09:54 am
Tags:
Novo Nordisk, Europe, hemophilia A, NovoEight
Is This Diabetes Drug Stock in Jeopardy?
Motley Fool
Sun, 09/15/13 - 12:25 pm
Tags:
Novo Nordisk, Victoza, diabetes, type 2 diabetes
Novo Nordisk Pushes Ahead In Challenging Year
Investors.com
Tue, 09/10/13 - 04:48 pm
Tags:
Novo Nordisk, Sanofi, Bristol-Myers Squibb, diabetes, Eli Lilly, MannKind
Another Prize Slips Through Novo's Hands As Big PBM Looks Elsewhere
Seeking Alpha
Thu, 09/5/13 - 08:24 am
Tags:
Novo Nordisk, diabetes
FDA clears Novo Nordisk insulin pen for children
Drugstore News
Thu, 08/22/13 - 09:11 am
Tags:
insulin pen, FDA, Novo Nordisk, NovoPen Echo, type 1 diabetes
MannKind's Steady Progression Towards FDA Approval Continues Unabated
Seeking Alpha
Mon, 08/19/13 - 09:43 am
Tags:
MannKind, FDA, Afrezza, diabetes, insulin, inhaled insulin, Eli Lilly, Pfizer, Novo Nordisk
U.S. Insulin Prices Rise as Sanofi, Novo Await Rivals
Bloomberg
Fri, 08/16/13 - 10:42 am
Tags:
insulin, diabetes, Sanofi, Novo Nordisk, Levemir, Lantus, Victoza
A Chinese Checkered History for Big Pharma
Motley Fool
Fri, 08/16/13 - 10:40 am
Tags:
China, GSK, Novo Nordisk, Bristol-Myers Squibb, Pfizer
Which are pharma's top 4 innovators? Hint: It's not the big guys
Fierce Pharma
Thu, 08/15/13 - 11:59 am
Tags:
innovation, Mylan, Novo Nordisk, Perrigo Company, Valeant Pharmaceuticals
This Week in Biotech
Motley Fool
Sun, 08/11/13 - 10:57 am
Tags:
Celgene, CompuGen, Bayer, Isis Pharmaceuticals, Onyx, Novo Nordisk, Amgen
Novo Nordisk Getting Its Trial By Fire
Investopedia
Fri, 08/9/13 - 09:44 am
Tags:
earnings, Novo Nordisk, diabetes, Teva, Eli Lilly, Sanofi
Top insulin maker Novo caught up in China's widening drug probes
Yahoo/Reuters
Thu, 08/8/13 - 08:59 am
Tags:
Novo Nordisk, China
Rexahn's CEO Uses A Business-Driven Cancer Model For Shareholder Value
Seeking Alpha
Tue, 08/6/13 - 10:49 am
Tags:
Rexahn, Merck, Novo Nordisk, Teva, Archexin, cancer
Oramed Expands Diabetes Platform With Oral GLP-1 Agonist
Seeking Alpha
Tue, 08/6/13 - 10:00 am
Tags:
GLP-1 agonist, diabetes, Oramed, Biodel, Bristol-Myers Squibb, Eli Lilly, MannKind, Novo Nordisk, Merck, Afrezza, Januvia, Victoza
Diabetes Drugs’ Pancreas Risk Not Backed by Evidence: EMA
Bloomberg
Fri, 07/26/13 - 09:03 am
Tags:
diabetes, Europe, Byetta, Bristol-Myers Squibb, Merck, Januvia, GLP-1 agonist, Novo Nordisk, Victoza
Novo Nordisk: A Pure Play In The Large And Lucrative Diabetes Care Sector
Seeking Alpha
Tue, 07/23/13 - 11:14 am
Tags:
Novo Nordisk, diabetes, MannKind, Merck
The Future of Sanofi's Insulin Empire
Motley Fool
Fri, 07/19/13 - 10:17 am
Tags:
Sanofi, insulin, Eli Lilly, Novo Nordisk, diabetes, U300, Lantus, LixiLan

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.